News
Viking Aktie: Übernahmejagd!
Viking Therapeutics erlebte gestern einen kräftigen Kurssprung von bis zu 5% – getrieben durch…
Der Beitrag Viking Aktie: Übernahmejagd! erschien zuerst auf kapitalmarktexperten.de.
Quelle kapitalma
Shares Down, Price Targets Up: 3 Stocks Upgraded After +10% Drops
While the market and Wall Street analysts often agree on the implications of earnings reports, this is certainly not always the case. A stock’s price action and changes in Wall Street price
Monday.com Opens Generational Opportunity With Manic Sell-Off
Monday.com’s (NASDAQ: MNDY) Q3 earnings release provided an excuse to sell, but the 20% decline posted in premarket action is an overreaction of epic proportions. The cause was guidance. The
EQS-News: Bilfinger SE: Aktienrückkauf
Analysts Keep Raving Over AppLovin: Targets Rise Post-Earnings
Advertising technology stock AppLovin (NASDAQ: APP) just reported its much-anticipated Q3 2025 earnings. Despite ups and downs, 2025 has been good to AppLovin. The company joined the S&P 500
Utz Insiders Signal Value With November Buys
Utz (NYSE: UTZ) insiders conspicuously purchased nearly $600,000 in shares of company stock in early November as its price retreated to a 52-week and multi-year low. This well-timed insider
EQS-News: Kontron Acquisition GmbH, mittelbare Tochtergesellschaft der Kontron AG beschließt aktienrechtlichen Squeeze-Out der KATEK SE, Ismaning/Deutschland
EQS-News: Kontron Acquisition GmbH, mittelbare Tochtergesellschaft der Kontron AG beschließt aktienrechtlichen Squeeze-Out der KATEK SE, Ismaning/Deutschland
2 Reasons to Buy Into Lam’s 185% Rally, 1 Reason to Run Away
Lam Research Corp. (NASDAQ: LRCX) has undoubtedly been one of 2025’s defining semiconductor stories. The Fremont-headquartered company designs and manufactures wafer-fabrication equipment, an
Großauftrag: HEIDELBERG/Amperfied übernimmt die Betriebsführung der Ladeinfrastruktur von Siemens Energy in Deutschland
EQS-News: Salzgitter-Konzern mit leicht positivem Vorsteuerergebnis im dritten Quartal
EQS-News: Hypoport mit profitablem Wachstum in 9M/25
Viking Therapeutics Aktie: Beeindruckende Geschäftsentwicklung!
Viking Aktie: Durchbruch gelungen! Viking Therapeutics sorgte am 4. November für Aufsehen, als das…
Der Beitrag Viking Therapeutics Aktie: Beeindruckende Geschäftsentwicklung! erschien zuerst auf ka
3 Big Earnings Misses: Is It Time to Buy the Dip?
Earnings season for Q3 2025 is well underway, but the exuberance from Q2 has faded. According to FactSet, more than 80% of S&P 500 companies reporting so far have beaten analysts’ expectations
Is Robinhood's 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
Shares of Robinhood Markets (NASDAQ: HOOD) just took their biggest hit in quite a while. On Nov. 6, shares closed down by nearly 11% as investors reacted to the firm’s Q3 2025 earnings. This was
AI Demand Is Coming—Is Microchip Technology Ready?
It’s taking time to show in the results, but Microchip Technology (NASDAQ: MCHP) is well-positioned to benefit from long-term demand for AI.
The story in 2025 is that of end-market
Intellia Aktie: Todesfall-Schock!
Intellia Aktie: Todesfall-Schock! Ein verheerender Rückschlag erschüttert Intellia Therapeutics: Nach dem Tod eines Patienten…
Der Beitrag Intellia Aktie: Todesfall-Schock! erschien zuerst auf kapit
Viking Therapeutics Aktie: Zockerpapier!
Viking Therapeutics Aktie: Zockerpapier! Die Biotech-Aktie von Viking Therapeutics sorgt erneut für Aufregung an…
Der Beitrag Viking Therapeutics Aktie: Zockerpapier! erschien zuerst auf kapitalmark
Rivian’s Chart Says Go, But Some Analysts Still Say No
Shares of Rivian Automotive Inc. (NASDAQ: RIVN) are once again on the verge of a breakout, as they knock on the door of the $15-16 level that bears have been defending vigorously all year. If they
e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
e.l.f. Beauty (NYSE: ELF) spooked the market with its fiscal Q2 release and guidance update on Nov. 5, creating a buying opportunity in the stock.
The causes of weaknesses include an
Intellia Therapeutics Aktie: Triste Bilanz!
Ein Todesfall in einer wichtigen Studie und ein sofortiger Stopp der Zulassungsbehörde FDA erschüttern…
Der Beitrag Intellia Therapeutics Aktie: Triste Bilanz! erschien zuerst auf kapitalmarktexpert
Amprius Technologies Signals Electrifying Growth in 2026
Amprius Technologies' (NYSE: AMPX) Q3 results were everything the market could have hoped for and more. Demand for the company’s silicon-anode lithium-ion batteries is surging, driving hypergrowth
Dave Stock: 180% Gain + Q3 Beat = Breakout Setup?
Los Angeles–based financial technology company Dave Inc. (NASDAQ: DAVE) has quietly become one of the market’s more intriguing small-cap momentum stocks to watch into year-end.
Dave's mission
Intellia Therapeutics Aktie: Alarmbereitschaft gefragt!
Das Biotechnologie-Unternehmen Intellia Therapeutics erlebt einen dramatischen Kurssturz nach der Bekanntgabe eines Todesfalls in…
Der Beitrag Intellia Therapeutics Aktie: Alarmbereitschaft gefragt!



